142 related articles for article (PubMed ID: 2447445)
1. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
[TBL] [Abstract][Full Text] [Related]
2. Antibodies in the serum and on the heart of dogs with cardiac allografts.
Goldman BS; Shumak KH; Silver MD; Cartier J; Lixfeld W; Bigelow WG; Crookston JH
Transplant Proc; 1971 Mar; 3(1):515-8. PubMed ID: 4937929
[No Abstract] [Full Text] [Related]
3. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
4. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.
Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC
J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464
[TBL] [Abstract][Full Text] [Related]
5. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
6. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
7. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Bouchard D; Despatis MA; Buluran J; Cartier R
Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
10. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin M antibodies in transplanted human hearts.
Labarrere CA; Pitts D; Halbrook H; Faulk WP
J Heart Lung Transplant; 1993; 12(3):394-402. PubMed ID: 8329409
[TBL] [Abstract][Full Text] [Related]
12. Immunostaining of cardiac biopsy specimens in the diagnosis of acute vascular (humoral) rejection: a control study.
Loy TS; Bulatao IS; Darkow GV; Demmy TL; Reddy HK; Curtis J; Bickel JT
J Heart Lung Transplant; 1993; 12(5):736-40. PubMed ID: 7694654
[TBL] [Abstract][Full Text] [Related]
13. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
[TBL] [Abstract][Full Text] [Related]
14. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
15. Endothelial activation and chronic allograft rejection.
Orosz CG
Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
[TBL] [Abstract][Full Text] [Related]
16. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation.
Brasile L; Zerbe T; Rabin B; Clarke J; Abrams A; Cerilli J
Transplantation; 1985 Dec; 40(6):672-5. PubMed ID: 3907041
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies.
LaVecchio JA; Dunne AD; Edge AS
Transplantation; 1995 Oct; 60(8):841-7. PubMed ID: 7482745
[TBL] [Abstract][Full Text] [Related]
18. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
Nakamura K; Murase N; Becich MJ; Furuya T; Todo S; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 1993 May; 142(5):1383-91. PubMed ID: 8494042
[TBL] [Abstract][Full Text] [Related]
19. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation.
Loh E; Bergin JD; Couper GS; Mudge GH
J Heart Lung Transplant; 1994; 13(2):194-201. PubMed ID: 8031799
[TBL] [Abstract][Full Text] [Related]
20. Natural antipig xenoantibody is absent in neonatal human serum.
Xu H; Edwards NM; Chen JM; Dong X; Michler RE
J Heart Lung Transplant; 1995; 14(4):749-54. PubMed ID: 7578185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
